SUMMARY
Nomura has an 'buy' call on the shares of HUL with a target price of Rs 3175 on its shares whereas Jefferies has an 'buy' call on the shares of Max Health with a target price of Rs 530 on its shares.
1 / 4
HUL | Nomura has a 'buy' call on the shares of HUL with a target price of Rs 3,175 on its shares. The brokerage house says that the company has right partners to accelerate growth momentum.
2 / 4HUL | CLSA has an 'outperform' call on the shares of HUL with a target price of Rs 2,950 on its shares. The brokerage house says that the company has potential for 300 billion market for vitamins and supplements in next five years.
3 / 4Max Health | Jefferies has a 'buy' call on the shares of Max Health with a target price of Rs 530 on its shares. The brokerage house says that the company has delivered exceptional operation performance in last two years.
4 / 4IT companies | Credit Suisse said that it expects top four IT companies to fall 10-27 percent and driven by valuation correction. It also added that it doesn't believe revision cuts will translate into large earnings cut.
